Arena Pharmaceuticals, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Two

Arena Pharmaceuticals, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Two

Arena Pharmaceuticals, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Two of $1.20 million as of 2016-12-31, per its 10-K filed 2017-03-15.

Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo · last filed 2017-03-15

• 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $1.20M.
• 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $600.00K.
• 2014-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $700.00K.